102 related articles for article (PubMed ID: 5031606)
1. Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
Piro AJ; Wilson RE; Hall TC; Aliapoulios MA; Nevinny HB; Moore FD
Arch Surg; 1972 Jul; 105(1):95-9. PubMed ID: 5031606
[No Abstract] [Full Text] [Related]
2. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
Hill GJ; Grage TB; Wilson W; Ansfield FJ
J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
[No Abstract] [Full Text] [Related]
3. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy in gastrointestinal cancer.
Reitemeier RJ; Moertel CG; Hahn RG
Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
[No Abstract] [Full Text] [Related]
5. Experience with ftorafur treatment in breast cancer.
Karev NI; Blokhina NG; Vozny EK; Pershin MP
Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
[No Abstract] [Full Text] [Related]
6. A clinical study of fluorouracil.
Nadler SH; Moore GE
Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
[No Abstract] [Full Text] [Related]
7. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
[No Abstract] [Full Text] [Related]
9. Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer.
Martoni A; Rani P; Ercolino L; Canova N; Pannuti F
Chemioterapia; 1988 Oct; 7(5):345-9. PubMed ID: 3224403
[TBL] [Abstract][Full Text] [Related]
10. Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.
Davis HL; Ramirez G; Ellerby RA; Ansfield FJ
Cancer; 1974 Aug; 34(2):239-45. PubMed ID: 4852055
[No Abstract] [Full Text] [Related]
11. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
Chang YC; Falkson G; Tormey DC; Crowley J
Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
[TBL] [Abstract][Full Text] [Related]
12. The variability of individual tolerance to methotrexate in cancer patients.
Hansen HH; Selawry OS; Holland JF; McCall CB
Br J Cancer; 1971 Jun; 25(2):298-305. PubMed ID: 4256007
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide therapy in patients with advancing breast cancer following adrenalectomy and 5-fluorouracil.
Piro AJ; Wilson RE; Nevinny HB
Cancer; 1971 Jun; 27(6):1342-5. PubMed ID: 5088210
[No Abstract] [Full Text] [Related]
14. A controlled evaluation of 5-fluorouracil utilizing a single injection technique.
Ahmann DL; Moertel CG; Bisel HF; Hahn RG; Schutt AJ; Dines DE
Oncology; 1974; 29(2):166-71. PubMed ID: 4836677
[No Abstract] [Full Text] [Related]
15. Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer.
Mohapatro SK; Dandapat MC; Padhi NC
J Indian Med Assoc; 1992 Feb; 90(2):39-42. PubMed ID: 1588118
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
Tormey DC; Gailani S; Leone L
Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
[No Abstract] [Full Text] [Related]
17. Clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma.
Stolinsky DC; Solomon J; Pugh RP; Stevens AR; Jacobs EM; Irwin LE; Wood DA; Steinfeld JL; Bateman JR
Cancer; 1970 Nov; 26(5):984-90. PubMed ID: 4920400
[No Abstract] [Full Text] [Related]
18. Treatment of advanced breast carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.
Chlebowski RT; Pugh RP; Weiner JM; Bateman JR
Cancer; 1981 Oct; 48(8):1711-4. PubMed ID: 7284972
[TBL] [Abstract][Full Text] [Related]
19. [Toxicities associated with chemotherapy in colorectal cancer].
Ura T; Shirao K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():374-8. PubMed ID: 14574916
[No Abstract] [Full Text] [Related]
20. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
